Summary
The Labrador Retriever carries a clinically distinctive gut health profile shaped by four converging biological drivers: a documented POMC gene mutation that disrupts appetite regulation and metabolic function in a significant proportion of the breed; a breed-level pattern of adverse food reactions recognised across multiple peer-reviewed studies; a documented predisposition to inflammatory bowel disease; and the microbiome consequences of obesity-driven gut dysbiosis. The gut-metabolic axis operates as the primary framework for this breed, with the gut-immune axis as a strong secondary dimension. Research directly comparing normal-weight and overweight Labrador Retrievers has identified breed-specific differences in intestinal microbiota composition, reinforcing the connection between bodyweight, breed genetics, and gut health. This article examines the science behind Labrador digestive vulnerability, what peer-reviewed evidence currently shows about breed-specific microbiome changes, and how targeted nutritional support may help maintain gut health across the breed’s most common presentations.
The Labrador Retriever is not simply Britain’s most-loved family dog. It is one of the most studied breeds in veterinary medicine, and for good reason. Labradors carry a genetic predisposition to obesity that traces directly to a specific mutation in the pro-opiomelanocortin (POMC) gene, disrupting the appetite-signalling peptides that would ordinarily tell the brain that the body has eaten enough. The result is a dog that frequently remains food-motivated well beyond adequate intake, whose weight management requires consistent owner vigilance, and whose digestive system faces the downstream consequences of chronic caloric excess and metabolic strain.
What makes the Labrador’s gut health picture particularly important is the degree to which these issues interconnect. Obesity reshapes the gut microbiome. Microbiome disruption fuels systemic inflammation. Systemic inflammation compounds food sensitivity reactions and elevates the risk of inflammatory bowel disease. Understanding these connections means recognising that managing a Labrador’s gut health cannot be separated from managing its weight, its immune reactivity, and its overall metabolic environment.
This guide examines the four key drivers of Labrador gut vulnerability, what peer-reviewed research reveals about breed-specific microbiome changes, and how owners can provide practical, evidence-informed nutritional support for one of the UK’s most cherished breeds.
Key Takeaways
- Approximately 25% of Labrador Retrievers carry a POMC gene deletion that disrupts appetite regulation and increases the risk of obesity and metabolic gut dysfunction.¹
- The gut-metabolic axis is the lead gut-health framework for this breed, with obesity-driven microbiome disruption creating measurable shifts in faecal bacterial composition.
- Labrador Retrievers are consistently documented among the breeds most frequently represented in adverse food reaction case series, alongside German Shepherd Dogs, Golden Retrievers, and West Highland White Terriers.²
- The breed carries a recognised risk of inflammatory bowel disease (IBD), with Labrador Retrievers identified among breeds at elevated risk in a UK-based study.³
- Protein-losing enteropathy, the severe end of the IBD spectrum, represents a serious complication in affected individuals and requires veterinary diagnosis and management.
- Research directly comparing normal-weight and overweight Labrador Retrievers has found breed-specific differences in intestinal microbiota composition, reinforcing the connection between bodyweight, breed genetics, and gut health.⁵
- Targeted prebiotic, probiotic, and postbiotic support may help maintain microbial balance in Labradors across all primary presentations.
In This Guide
- The Anatomy of Labrador Gut Vulnerability
- Food Sensitivity and Adverse Food Reactions
- IBD and Protein-Losing Enteropathy in Labradors
- Labrador Gut Dysbiosis: What the Research Shows
- How Bonza Supports Labrador Gut Health
- How To Support Your Labrador’s Gut Health: A Practical Guide
- Safety Considerations and When to See Your Vet
- Frequently Asked Questions
- Conclusion
- Related Articles
- References
- Editorial Information
The Anatomy of Labrador Gut Vulnerability
The POMC Mutation and Its Gut Consequences
In 2016, researchers at the University of Cambridge published landmark findings in Cell Metabolism identifying a 14 base-pair deletion in the pro-opiomelanocortin (POMC) gene in Labrador Retrievers and the closely related Flat-Coated Retriever.¹ The deletion disrupts the production of two key neuroactive peptides: beta-melanocyte-stimulating hormone (β-MSH) and beta-endorphin. These peptides are involved in signalling satiety following a meal. When their production is impaired, the brain does not receive adequate signals to end the sensation of hunger, and the dog remains food-motivated even after consuming an adequate ration.
The study identified the POMC deletion with an allele frequency of approximately 12% in a general Labrador population, with estimates suggesting that around 25% of individual dogs carry at least one copy of the mutation.¹ The deletion was associated with increased body weight, higher adiposity scores, and significantly greater food motivation. Importantly, the mutation was not identified in any of the other breeds studied, appearing exclusively in Labradors and Flat-Coated Retrievers, confirming it as a breed-specific genetic driver rather than a broader canine phenomenon.¹
The gut consequences of this mutation operate through several interconnected pathways. Chronic caloric excess, driven by impaired satiety signalling, increases adipose tissue accumulation. Excess adiposity generates systemic low-grade inflammation through pro-inflammatory cytokines produced by fat cells. This inflammatory environment reaches the gut, disrupting the intestinal epithelial barrier, altering the composition of the gut microbiome, and creating conditions that favour dysbiosis over a healthy microbial balance. In the Labrador, obesity is not simply a body composition issue: it is a gut health issue.
The Gut-Metabolic Axis in Labradors
The gut-metabolic axis describes the bidirectional relationship between the gut microbiome and the body’s metabolic systems, including energy regulation, insulin sensitivity, lipid metabolism, and inflammatory signalling. In the Labrador Retriever, this axis is under particular strain. You can explore the broader science of this relationship in Bonza’s dedicated guide: The Gut-Metabolic Axis in Dogs: Powerful Health Regulator.
Research on canine obesity consistently demonstrates that overweight dogs carry a measurably different faecal microbiome compared to lean counterparts. A 2022 study published in PeerJ, examining the intestinal microbiome of obese and normal-weight adult dogs, found that obese dogs showed a significant decrease in Bacteroidetes and an increase in Firmicutes relative to lean controls.⁷ This shift in the Firmicutes-to-Bacteroidetes ratio has been associated with increased capacity for energy extraction from food, creating a feedback loop in which dysbiosis amplifies the metabolic consequences of overconsumption.
A 2022 study published in Scientific Reports compared the intestinal microbiota of normal-weight and overweight Labrador Retrievers and Border Collies directly, finding breed-specific differences in microbiota composition alongside variation related to bodyweight and dietary protein intake.⁵ The findings reinforced the principle that a Labrador’s gut microbial environment is shaped not only by its current diet and weight, but by breed-level genetic architecture.
The gut-metabolic axis in the Labrador also intersects with the gut-joint axis. The breed’s obesity predisposition increases mechanical load on joints, and the systemic inflammation generated by excess adipose tissue and microbiome disruption contributes directly to joint tissue degradation. For Labrador owners managing a dog with weight concerns alongside reduced mobility or stiffness, the connection between gut health, metabolic function, and joint integrity is clinically relevant and practically important.
Food Sensitivity and Adverse Food Reactions
The Labrador Retriever is consistently documented among the breeds most frequently represented in cutaneous adverse food reaction (CAFR) case series. A critically appraised topic review published in BMC Veterinary Research in 2019, drawing on data from multiple peer-reviewed studies, found that German Shepherd Dogs, Labrador Retrievers, Golden Retrievers, and West Highland White Terriers together accounted for approximately 40% of dogs presenting with cutaneous adverse food reactions across the reviewed literature.² The authors noted that these four breeds appeared repeatedly across studies conducted in different countries and over different time periods, indicating a consistent observational pattern. They also acknowledged that no firm causal predisposition data exists to confirm whether breed representation reflects a true biological susceptibility or partially reflects breed prevalence in the general dog population.²
Adverse food reactions (AFRs) in dogs can present through cutaneous signs, gastrointestinal signs, or both. In Labradors, owners most commonly observe loose stools, intermittent vomiting, flatulence, and dermatological signs including generalised pruritus, ear inflammation, and recurrent skin infections. These signs may develop at any age, and a dog that has tolerated a specific protein source for years may develop a reaction to it as immune sensitisation accumulates over time.
The Labrador’s well-documented food drive, itself amplified in POMC-affected individuals, compounds the practical challenge of managing food sensitivity. Dietary indiscretion, scavenging, and counter-surfing introduce novel antigens that complicate identification of dietary triggers and undermine the strict dietary control required for diagnostic elimination trials. An elimination diet conducted over 8 to 12 weeks under veterinary guidance remains the gold standard for diagnosing adverse food reactions in this breed.
Dietary management of confirmed food sensitivity typically involves a novel protein or hydrolysed protein diet. Alongside dietary change, gut microbiome support is increasingly recognised as an adjunct to managing food-responsive enteropathy, given the documented relationship between dysbiosis and intestinal immune reactivity. The gut-immune axis, explored in Bonza’s dedicated article The Gut-Immune Axis in Dogs: How Gut Health Supports Immune Health, provides important additional context for understanding how microbiome disruption may amplify food-reactive symptoms.
IBD and Protein-Losing Enteropathy in Labradors
A 2011 study published in Veterinary Record, conducted by researchers at the Royal Veterinary College, identified the Labrador Retriever among the breeds at elevated risk of developing inflammatory bowel disease in the south-eastern United Kingdom.³ Canine chronic inflammatory enteropathy encompasses a spectrum of conditions characterised by persistent gastrointestinal signs of three weeks or longer, with diagnosis based on clinical presentation, response to dietary or pharmacological intervention, and, in some cases, histopathological evidence of intestinal mucosal inflammation.
Within this spectrum, protein-losing enteropathy (PLE) represents the most clinically severe presentation. PLE is defined by excessive loss of serum proteins, particularly albumin, across the intestinal wall, and is most commonly associated with inflammatory bowel disease, intestinal lymphangiectasia, or intestinal neoplasia. The hallmark laboratory finding is hypoalbuminaemia, which may be accompanied by lymphopenia, hypocholesterolaemia, hypocalcaemia, and hypomagnesaemia. Clinical signs include chronic diarrhoea, vomiting, weight loss, and, in severe cases, ascites or peripheral oedema resulting from sustained protein depletion.
PLE carries a guarded prognosis and requires veterinary diagnosis and intensive management. For the majority of Labrador owners, however, the spectrum of concern begins earlier, with food-responsive or immune-mediated enteropathy presenting as chronic digestive upset, fluctuating stool consistency, and poor nutrient absorption. Gut microbiome support is relevant across this entire spectrum, with the underlying dysbiosis that characterises both IBD and food-responsive enteropathy providing a rational target for nutritional intervention.
The gut-immune axis is the secondary framework for understanding IBD in the Labrador. The intestinal immune system, which houses the majority of the body’s immune cells, loses its capacity to maintain appropriate tolerance to commensal bacteria and food antigens in the context of dysbiosis, intestinal barrier compromise, and chronic inflammation. Addressing the microbiome does not replace immunosuppressive or dietary veterinary treatment where that is required, but it supports the environment in which intestinal immune balance operates.
Labrador Gut Dysbiosis: What the Research Shows
Dysbiosis, the disruption of a healthy and diverse gut microbial community, sits at the intersection of all four Labrador gut health presentations described in this guide. Whether the primary driver is the metabolic consequences of the POMC mutation, an adverse food reaction, or immune-mediated enteropathy, dysbiosis is both a contributing factor and a downstream consequence.
A 2023 study published in Scientific Reports, examining fecal microbiome differences between obese and normal-weight dogs, found measurable shifts in specific microbial taxa in overweight animals, with distinct microbial network structures in obese dogs compared to lean controls.⁶ The obese group showed alterations in key genera associated with energy metabolism and intestinal immune regulation. In the context of the Labrador, where breed genetics actively increase the risk of obesity, these findings carry direct clinical relevance.
The 2022 Morelli et al. study that directly compared the intestinal microbiota of Labrador Retrievers and Border Collies found that bacterial taxa previously identified in obesity-related research differed between the two breeds, with Labradors showing breed-specific microbiota characteristics even when controlling for body condition score.⁵ The study used 16S rRNA gene sequencing in young adult, intact, antibiotic-naive companion dogs and found that certain phyla-level patterns varied by breed independently of body condition, suggesting that a Labrador’s baseline gut microbial environment reflects breed-level biological architecture rather than diet or weight alone.
A broader 2022 study using predicted functional profiling of the canine gut microbiome found that obese dogs showed an increased Firmicutes-to-Bacteroidetes ratio alongside predicted functional shifts in energy extraction from complex carbohydrates.⁷ These functional changes connect microbiome composition to systemic metabolic outcomes, reinforcing the gut-metabolic axis as the central lens for the Labrador’s health profile.
At a functional level, dysbiosis in dogs is associated with reduced short-chain fatty acid production, impaired intestinal barrier integrity, elevated intestinal permeability, altered tryptophan metabolism, and shifts in bile acid processing. Each of these functional changes connects the gut microbiome to systemic immunity, metabolic regulation, and inflammatory signalling. For the Labrador, where all three systems are under breed-level pressure, proactive microbiome support is a meaningful investment rather than an optional enhancement.
How Bonza Supports Labrador Gut Health
Two Bonza Bioactive Bites products carry particular relevance for the Labrador Retriever, reflecting the breed’s two primary gut health presentations. They are designed as complementary rather than competing products, and the appropriate lead choice depends on the owner’s primary presenting concern.
Boost: For the Metabolic and Gut-Joint Presentation
For Labrador owners whose primary concern is the metabolic consequences of the POMC mutation and the breed’s obesity predisposition, Boost is the lead recommendation. Boost is formulated to address the gut-metabolic and gut-joint axes simultaneously, delivering bioactive ingredients that are particularly relevant to the Labrador’s most common systemic challenges.
MSM, chondroitin, hyaluronic acid, and ASU (avocado soya unsaponifiables) support joint tissue integrity, which is directly relevant in a breed where weight predisposition places elevated mechanical and inflammatory load on joints. Turmeric and Boswellia provide systemic inflammatory modulation that may help maintain healthy inflammatory responses in a breed where adipose-driven inflammation is a recognised concern. The full Biotics Triad, comprising prebiotics, the live probiotic Calsporin® (Bacillus velezensis DSM 15544), and postbiotics including TruPet™ and Lactobacillus helveticus HA-122, addresses the underlying microbiome disruption that connects metabolic dysfunction to gut health.
Belly: For the Digestive Sensitivity Presentation
For Labrador owners whose primary concern is loose stools, digestive upset, food sensitivity reactions, post-antibiotic gut disruption, or malabsorption-related symptoms, Belly is the lead recommendation. Belly delivers targeted prebiotic and digestive support ingredients that may help maintain gut barrier integrity and microbial balance in a breed prone to dietary indiscretion and food-responsive enteropathy.
Biotics: Universal Microbiome Foundation
Biotics is appropriate for all Labrador owners regardless of which primary presentation is most relevant. As the core daily microbiome supplement, Biotics delivers the complete Biotics Triad to support microbial diversity and resilience. Calsporin® (Bacillus velezensis DSM 15544), Bonza’s live probiotic strain, is supported by prebiotics and postbiotics in a formulation designed to address the underlying dysbiosis common across all Labrador gut presentations.
For our full supplement recommendations and a practical protocol built specifically for Labradors, see: Best Gut Health Supplements for Labradors: A Canine Nutritionist’s Guide.
Note: PhytoPlus® is a proprietary blend of bioactive ingredients found exclusively in Bonza’s Superfoods and Ancient Grains complete food. It is not present in any Bioactive Bites supplements.
How To Support Your Labrador’s Gut Health: A Practical Guide
The steps below provide a practical framework for Labrador owners looking to support their dog’s gut health through consistent daily habits and informed nutritional choices. They are intended as general guidance for healthy adult Labradors. Always consult a veterinarian before making significant changes to your dog’s diet or supplement regimen, particularly where clinical signs of digestive distress are already present.
- Assess and monitor bodyweight consistently
Weigh your Labrador monthly and track body condition score (BCS) on a validated 9-point scale. Work with your veterinarian to establish a healthy weight target and adjust caloric intake before weight gain becomes entrenched. Early weight management is gut health management in this breed.
- Choose a diet appropriate to the breed’s risk profile
Select a nutritionally complete diet that provides adequate dietary fibre to support gut motility and microbiome diversity. Avoid frequent, unplanned diet changes unless undertaking a structured elimination trial for suspected food sensitivity under veterinary guidance.
- Introduce daily microbiome support as a consistent foundation
Incorporate a daily prebiotic, probiotic, and postbiotic supplement as ongoing gut maintenance. Biotics provides the full Biotics Triad and is suitable for all Labrador Retrievers as daily microbiome support, regardless of whether additional targeted supplementation is also used.
- Match targeted supplementation to the primary concern
If your Labrador’s main challenges are weight management, systemic inflammation, or joint discomfort alongside digestive signs, Boost is the appropriate lead product. If digestive sensitivity, loose stools, or food-responsive symptoms are the primary presentation, Belly is the appropriate lead.
- Manage dietary indiscretion proactively
Given the Labrador’s food drive, limit access to food sources outside structured mealtimes. Secure bin lids, restrict counter access, and ensure all household members follow consistent feeding protocols. Scavenging is a significant source of microbiome disruption and potential antigen exposure in this breed.
- Reduce unnecessary antibiotic exposure where possible
Antibiotics significantly disrupt the gut microbiome. Discuss antibiotic stewardship with your veterinarian and support the gut microbiome with probiotics during and after any antibiotic course.
- Monitor for red-flag clinical signs and seek veterinary advice promptly
See the section below for warning signs that require veterinary assessment rather than management at home.
Safety Considerations and When to See Your Vet
The nutritional support described in this guide is appropriate for general gut health maintenance in healthy adult Labrador Retrievers. It does not replace veterinary diagnosis or treatment of clinical gastrointestinal disease, and it is not intended for use in dogs with active, undiagnosed digestive illness without veterinary involvement.
Seek veterinary attention promptly if your Labrador displays any of the following signs:
- Persistent diarrhoea lasting more than 48 hours, or bloody diarrhoea at any point
- Vomiting more than once daily or vomiting blood
- Significant or unexplained weight loss
- Abdominal swelling or distension
- Lethargy, loss of appetite, or collapse
- Oedema (swelling) in the limbs, abdomen, or face
- Pale mucous membranes
These signs may indicate conditions including protein-losing enteropathy, intestinal obstruction, pancreatitis, or other serious gastrointestinal disease, all of which require veterinary assessment and, in many cases, laboratory diagnostics, endoscopy, or intestinal biopsy.
When investigating chronic digestive signs in a Labrador, your veterinarian may recommend serum albumin measurement, cobalamin (vitamin B12) assessment, canine trypsin-like immunoreactivity (cTLI) testing to exclude exocrine pancreatic insufficiency, and a canine microbiota dysbiosis index to quantify the degree of gut microbiome disruption. These investigations provide actionable data that can guide both dietary and supplement choices.
Frequently Asked Questions
Not all Labradors will develop significant gut disease, but the breed carries several documented predispositions that make proactive gut health support worthwhile for the majority of owners. The POMC mutation is present in an estimated 25% of the breed population, food sensitivity is documented as a consistent breed-level pattern across multiple studies, and IBD risk is recognised as elevated compared to many other breeds. Proactive microbiome support is a sound preventive investment regardless of current clinical status.
Common signs include intermittent loose stools, flatulence, vomiting, generalised itching, recurrent ear infections, and poor coat quality. These signs are non-specific and may also reflect environmental allergies or other conditions. An elimination diet trial under veterinary guidance, typically conducted over 8 to 12 weeks using a novel protein or hydrolysed protein diet, is the gold standard diagnostic approach. Blood tests for food allergy are available but have limited diagnostic sensitivity and specificity compared to dietary elimination trials.
Any dog can develop EPI, and it should be included in the differential diagnosis for a Labrador presenting with malabsorption symptoms. However, it is important to note that a large-scale study of over 13,000 trypsin-like immunoreactivity assays found that Labrador Retrievers were actually significantly underrepresented in the EPI-positive population compared to the general canine population, suggesting the breed does not carry a specific predisposition to the condition.⁴ German Shepherd Dogs remain the most commonly affected breed. If your Labrador displays signs of malabsorption, including markedly increased appetite, voluminous pale stools, weight loss despite adequate intake, and coprophagia, EPI should be excluded by your veterinarian using the cTLI assay.
PLE is a serious condition in which intestinal disease causes excessive protein loss through the gut wall, leading to dangerously low blood albumin and associated complications including fluid accumulation and thromboembolism. It represents the severe end of the inflammatory bowel disease spectrum and requires prompt veterinary diagnosis and treatment. Most Labradors will not develop PLE, but owners should familiarise themselves with the warning signs listed in the safety section above and seek veterinary attention without delay if any are present.
Yes. Bonza’s Superfoods and Ancient Grains is a nutritionally complete plant-based diet suitable for adult Labrador Retrievers. Given the breed’s caloric management requirements, accurate portion control is important and best confirmed with veterinary weight monitoring. The food contains PhytoPlus, a bioactive ingredient exclusive to the complete food formula and not present in any Bioactive Bites supplement.
Boost and Belly are designed as complementary products addressing different primary presentations. Some Labrador owners may find both relevant, for example where metabolic and joint concerns coexist with digestive sensitivity. Add Biotics as the universal microbiome foundation and discuss your individual dog’s profile with your veterinarian to determine the most appropriate combination.
Conclusion
The Labrador Retriever is a breed for whom gut health cannot be understood in isolation. Its well-documented POMC mutation does not simply create a food-motivated dog: it creates a dog whose metabolic environment, inflammatory tone, and gut microbiome are all under greater pressure than those of most other breeds. The resulting picture, combining obesity risk, food sensitivity, IBD predisposition, and breed-specific microbiome characteristics, demands a gut health approach that treats these systems as connected rather than separate.
What the research makes clear is that the gut-metabolic axis is the Labrador’s primary gut health lens. Weight management is gut health management in this breed. The gut-immune axis runs as a strong secondary framework, and the gut microbiome sits at the intersection of both. Supporting microbial diversity and resilience through the Biotics Triad is not an optional enhancement for the Labrador: it is a foundational investment in the breed’s long-term wellbeing. The Labrador’s extraordinary generosity of spirit, its readiness for work, for play, and for companionship, deserves a gut health strategy that matches it in ambition and in science.
Related Articles
- The Dog Gut Microbiome: Vital Key to Dog Health
- The Gut-Immune Axis in Dogs: How Gut Health Supports Immune Health
- The Gut-Metabolic Axis in Dogs: Powerful Health Regulator
- Best Probiotics for Dogs: Canine Nutritionist’s Guide to Real Gut Impact
- Best Prebiotics for Dogs: Canine Nutritionist’s Complete Guide
- Gut Dysbiosis in Dogs: Causes, Symptoms & How to Restore Balance
References
- Raffan E, Dennis RJ, O’Donovan CJ, et al. A deletion in the canine POMC gene is associated with weight and appetite in obesity-prone Labrador Retriever dogs. Cell Metab. 2016;23(5):893-900. doi: 10.1016/j.cmet.2016.04.012. PMID: 27157046. PMC: PMC4873617.
- Olivry T, Mueller RS. Critically appraised topic on adverse food reactions of companion animals (7): signalment and cutaneous manifestations of dogs and cats with adverse food reactions. BMC Vet Res. 2019;15(1):140. doi: 10.1186/s12917-019-1880-2. PMID: 31072328.
- Kathrani A, Werling D, Allenspach K. Canine breeds at high risk of developing inflammatory bowel disease in the south-eastern UK. Vet Rec. 2011;169(24):635. doi: 10.1136/vr.d5380. PMID: 21896567.
- Batchelor DJ, Noble PJM, Cripps PJ, Taylor RH, McLean L, Leibl MA, German AJ. Breed associations for canine exocrine pancreatic insufficiency. J Vet Intern Med. 2007;21(2):207-214. doi: 10.1111/j.1939-1676.2007.tb02950.x. PMID: 17427378.
- Morelli G, Patuzzi I, Losasso C, Ricci A, Contiero B, Andrighetto I, Ricci R. Characterisation of intestinal microbiota in normal weight and overweight Border Collie and Labrador Retriever dogs. Sci Rep. 2022;12(1):9199. doi: 10.1038/s41598-022-13270-6. PMID: 35655089. PMC: PMC9163050.
- Kim H, Seo J, Park T, Seo K, Cho HW, Chun JL, Kim KH. Obese dogs exhibit different fecal microbiome and specific microbial networks compared with normal weight dogs. Sci Rep. 2023;13(1):723. doi: 10.1038/s41598-023-27846-3. PMID: 36639715. PMC: PMC9839755.
- Thomson P, Santibáñez R, Rodríguez-Salas C, Flores-Yañez C, Garrido D. Differences in the composition and predicted functions of the intestinal microbiome of obese and normal weight adult dogs. PeerJ. 2022;10:e12695. doi: 10.7717/peerj.12695. PMID: 35190784. PMC: PMC8857902.
Editorial Information
| Field | Detail |
|---|---|
| Published | March 2026 |
| Last Updated | March 2026 — this article is reviewed annually or following the publication of significant new peer-reviewed evidence |
| Reviewed by | Glendon Lloyd, Diploma in Canine Nutrition (Distinction), Diploma in Canine Nutrigenomics (Distinction) |
| Next Review | March 2027 |
| Author | Glendon Lloyd |
| Disclaimer | This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your dog’s diet or supplement regimen. |
